Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on HMPL 504. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.